Australia Non-opioid Pain Treatment Market Size & Outlook
Related Markets
Australia non-opioid pain treatment market highlights
- The Australia non-opioid pain treatment market generated a revenue of USD 845.0 million in 2024 and is expected to reach USD 1,416.3 million by 2030.
- The Australia market is expected to grow at a CAGR of 9.1% from 2025 to 2030.
- In terms of segment, nsaids was the largest revenue generating drug class in 2024.
- Local Anesthetics is the most lucrative drug class segment registering the fastest growth during the forecast period.
Non-opioid pain treatment market data book summary
| Market revenue in 2024 | USD 845.0 million |
| Market revenue in 2030 | USD 1,416.3 million |
| Growth rate | 9.1% (CAGR from 2025 to 2030) |
| Largest segment | Nsaids |
| Fastest growing segment | Local Anesthetics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NSAIDs, Acetaminophen, Local Anesthetics |
| Key market players worldwide | Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, GSK PLC ADR, Pfizer Inc, Perrigo Co PLC, LNK International Inc., Cipla Ltd DR, Johnson & Johnson, Pacira BioSciences Inc, Pierrel S.p.A |
Other key industry trends
- In terms of revenue, Australia accounted for 1.9% of the global non-opioid pain treatment market in 2024.
- Country-wise, Mexico is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan non-opioid pain treatment market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,129.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-opioid Pain Treatment Market Scope
Non-opioid Pain Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Pierrel S.p.A | View profile | 501-1000 | Capua, Campania, Italy, Europe | http://www.pierrelgroup.com |
| LNK International Inc. | View profile | 1001-5000 | Hauppauge, New York, United States, North America | http://linkintl.com |
| Pacira BioSciences Inc | View profile | 712 | 5401 West Kennedy Boulevard, Suite 890, Tampa, FL, United States, 33609 | https://www.pacira.com |
| Perrigo Co PLC | View profile | 9140 | The Sharp Building, Hogan Place, Dublin, Ireland, D02 TY74 | https://www.perrigo.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://www.drreddys.com/ |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Australia non-opioid pain treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-opioid pain treatment market will help companies and investors design strategic landscapes.
Nsaids was the largest segment with a revenue share of 58.78% in 2024. Horizon Databook has segmented the Australia non-opioid pain treatment market based on nsaids, acetaminophen, local anesthetics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia non-opioid pain treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia non-opioid pain treatment market databook
-
Our clientele includes a mix of non-opioid pain treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia non-opioid pain treatment market , including forecasts for subscribers. This country databook contains high-level insights into Australia non-opioid pain treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia Drug Class - Non-opioid Pain Treatment Market size, 2024 - 2030 (US$M)
Australia Non-opioid Pain Treatment Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
